Market Access NICE’s health inequalities modular update: A positive step, ... The start of a new year saw the launch of a consultation on NICE’s eagerly anticipated health inequalities modular update to the manual for health technology evaluation.1
Patients Putting patients at the centre of innovation starts with cli... A reliable and sustainable clinical trial system plays a pivotal role in supporting patients with unmet needs.
Oncology How quality of life can drive equitable cancer care and outc... Health inequalities are increasingly evident and affect more people than ever.
Oncology Sponsored Oncology in the NHS: Situations, challenges, and solutions Oncology is a singularly complex healthcare area.
Patients Using co-creation to tackle health inequalities through tran... Vani Manja is the country MD and head of human pharma at Boehringer Ingelheim UK & Ireland.
Views & Analysis Listening to the Patient Voice: Collaborate to meet unmet in... Pharma has a real willingness to listen to the patient voice – but how best can we turn that desire into action?
News Bayer trial combines two top drugs for kidney disease Data from the CONFIDENCE trial shows the value of combining Bayer's Kerendia with an SGLT2 inhibitor to treat chronic kidney disease in diabetics.